Status:
COMPLETED
The Effect of Colchicine on Platelet Function Profiles in Patients With Stable Coronary Artery Disease
Lead Sponsor:
The University of The West Indies
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The effects of colchicine on cardiovascular health in patients with stable coronary artery disease have been shown to be beneficial due to its anti-inflammatory properties. This present study aims to ...
Detailed Description
Recent landmark clinical trials on the use of colchicine in patients with chronic coronary artery disease has led to its implementation as an FDA approved drug for secondary prevention in patients wit...
Eligibility Criteria
Inclusion
- Patients with stable coronary artery disease.
- Patients older than 18 years of age.
- Patients currently on dual anti platelets, aspirin and clopidogrel
Exclusion
- • Patients already on colchicine
Key Trial Info
Start Date :
August 21 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 4 2024
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT06567678
Start Date
August 21 2024
End Date
November 4 2024
Last Update
August 11 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of The West Indies
Saint Augustine, Trinidad and Tobago